[1]
“In Silico Insights into the Impact of Deleterious SNPs on the Functioning and Dynamics of TP53 and Its Targeted Therapy by COTI-2 and PRIMA1 in Breast Cancer Patients”, UCP J. Sci. Technol., vol. 3, no. 2, pp. 31–58, Jul. 2026, doi: 10.24312/ucp-jst.03.02.523.